Nu Skin Enterprises Beheer

Beheer criteriumcontroles 2/4

De CEO Nu Skin Enterprises is Ryan Napierski, benoemd in Mar2017, heeft een ambtstermijn van 7.67 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 5.84M, bestaande uit 17% salaris en 83% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.21% van de aandelen van het bedrijf, ter waarde € 730.49K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 12.1 jaar en 12.1 jaar.

Belangrijke informatie

Ryan Napierski

Algemeen directeur

US$5.8m

Totale compensatie

Percentage CEO-salaris	17.0%
Dienstverband CEO	7.7yrs
Eigendom CEO	0.2%
Management gemiddelde ambtstermijn	12.1yrs
Gemiddelde ambtstermijn bestuur	12.1yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Ryan Napierski's beloning veranderd ten opzichte van Nu Skin Enterprises's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	-US$103m
Jun 30 2024	n/a	n/a	-US$148m
Mar 31 2024	n/a	n/a	-US$3m
Dec 31 2023	US$6m	US$992k	US$9m
Sep 30 2023	n/a	n/a	US$59m
Jun 30 2023	n/a	n/a	US$70m
Mar 31 2023	n/a	n/a	US$77m
Dec 31 2022	US$5m	US$942k	US$105m
Sep 30 2022	n/a	n/a	US$38m
Jun 30 2022	n/a	n/a	US$113m
Mar 31 2022	n/a	n/a	US$139m
Dec 31 2021	US$5m	US$801k	US$147m
Sep 30 2021	n/a	n/a	US$230m
Jun 30 2021	n/a	n/a	US$237m
Mar 31 2021	n/a	n/a	US$219m
Dec 31 2020	US$4m	US$721k	US$191m
Sep 30 2020	n/a	n/a	US$158m
Jun 30 2020	n/a	n/a	US$146m
Mar 31 2020	n/a	n/a	US$150m
Dec 31 2019	US$2m	US$688k	US$174m
Sep 30 2019	n/a	n/a	US$116m
Jun 30 2019	n/a	n/a	US$125m
Mar 31 2019	n/a	n/a	US$129m
Dec 31 2018	US$3m	US$621k	US$122m
Sep 30 2018	n/a	n/a	US$158m
Jun 30 2018	n/a	n/a	US$146m
Mar 31 2018	n/a	n/a	US$137m
Dec 31 2017	US$3m	US$594k	US$129m

Compensatie versus markt: De totale vergoeding ($USD 5.84M ) Ryan } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de German markt ($USD 1.03M ).

Compensatie versus inkomsten: De vergoeding van Ryan is gestegen terwijl het bedrijf verliesgevend is.

CEO

Ryan Napierski (50 yo)

7.7yrs

Tenure

US$5,838,579

Compensatie

Mr. Ryan S. Napierski has been Chief Executive Officer of Nu Skin Enterprises Inc. since September 1, 2021. Mr. Napierski has been the President of Nu Skin Enterprises Inc. since March 7, 2017 and has been...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Steven Lund	Co-Founder & Executive Chairman of the Board	28.8yrs	US$856.61k	0.24% € 835.7k
Ryan Napierski	President	7.7yrs	US$5.84m	0.21% € 730.5k
James Thomas	Executive VP	5.3yrs	US$1.86m	0.14% € 504.8k
Joseph Chang	Executive VP & Chief Scientific Officer	18.8yrs	US$1.12m	0.19% € 648.0k
Chayce Clark	Executive VP & General Counsel	3.3yrs	US$2.28m	0.32% € 1.1m
Steve Hatchett	Executive VP & Chief Product Officer	6.8yrs	US$1.41m	0.19% € 674.0k
Blake Roney	Founder	40.8yrs	US$621.69k	geen gegevens
Sandra Tillotson	Founder	28.8yrs	US$1.06m	geen gegevens
Joe Sueper	Senior VP & CTO	3.8yrs	geen gegevens	geen gegevens
Mark Adams	Chief Information Officer	18.8yrs	geen gegevens	geen gegevens
Scott Pond	Vice President of Investor Relations	no data	geen gegevens	geen gegevens
Ashok Pahwa	Chief Marketing Officer	16.5yrs	geen gegevens	geen gegevens

12.1yrs

Gemiddelde duur

66yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van NUS is doorgewinterd en ervaren (gemiddelde ambtstermijn van 12.1 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Steven Lund	Co-Founder & Executive Chairman of the Board	28.8yrs	US$856.61k	0.24% € 835.7k
Ryan Napierski	President	3.4yrs	US$5.84m	0.21% € 730.5k
Edwina Woodbury	Independent Director	9.4yrs	US$273.20k	0.033% € 115.3k
Daniel Campbell	Lead Independent Director	27.7yrs	US$280.20k	0.21% € 741.0k
Lars Bohlin	Member of Anti-Aging Scientific Advisory Board	no data	geen gegevens	geen gegevens
Thomas Pisano	Independent Director	16.4yrs	US$257.08k	0.15% € 506.0k
Zoe Draelos	Member of the Anti-Aging Scientific Advisory Board	14.8yrs	geen gegevens	geen gegevens
Paul Cox	Member of Anti-Aging Scientific Advisory Board	no data	geen gegevens	geen gegevens
Tomas Prolla	Member of Anti-aging Scientific Advisory Board	15.1yrs	geen gegevens	geen gegevens
Zheqing Shen	Director	8.3yrs	US$249.20k	0.044% € 153.3k
Laura Nathanson	Independent Director	5.4yrs	US$268.20k	0.044% € 151.6k
Emma Battle	Independent Director	3.4yrs	US$264.33k	0.039% € 134.8k

12.1yrs

Gemiddelde duur

67.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van NUS zijn ervaren en ervaren (gemiddelde ambtstermijn van 12.1 jaar).

Nu Skin Enterprises Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Nu Skin Enterprises Appoints Mark A. Zorko to its Board of Directors and Audit Committee and Nominating and Corporate Governance Committee

Insufficient new directors

Nu Skin Enterprises, Inc., Annual General Meeting, Jun 05, 2024

Independent Director recently sold €254k worth of stock

Nu Skin Enterprises, Inc. Appoints James D. Thomas as Chief Financial Officer

Chief Accounting Officer recently sold €110k worth of stock

Recent updates

Third quarter dividend of US$0.06 announced

Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on December 11, 2024

Third quarter 2024 earnings released: EPS: US$0.17 (vs US$0.74 loss in 3Q 2023)

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024 and Adjusts Earnings Guidance for the Year 2024

Nu Skin Introduces MYND360™, a New Line of Clinically Proven Supplements and Topicals for Mental Well-Being

Nu Skin Enterprises, Inc. to Report Q3, 2024 Results on Nov 07, 2024

Nu Skin Enterprises Appoints Mark A. Zorko to its Board of Directors and Audit Committee and Nominating and Corporate Governance Committee

Upcoming dividend of US$0.06 per share

New minor risk - Share price stability

New major risk - Revenue and earnings growth

Nu Skin Enterprises, Inc. Revises Financial Guidance for the Full Year of 2024

Nu Skin Enterprises, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Insufficient new directors

Upcoming dividend of US$0.06 per share

First quarter dividend of US$0.06 announced

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Second Quarter of 2024

First quarter 2024 earnings released: US$0.011 loss per share (vs US$0.23 profit in 1Q 2023)

Nu Skin Enterprises, Inc. Announces Quarterly Dividend, Payable on June 12, 2024

Now 21% undervalued after recent price drop

Nu Skin Enterprises, Inc., Annual General Meeting, Jun 05, 2024

Nu Skin Enterprises, Inc. to Report Q1, 2024 Results on May 08, 2024

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Now 22% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 22%

Fourth quarter dividend of US$0.06 announced

Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on March 6, 2024

Nu Skin Enterprises, Inc. to Report Q4, 2023 Results on Feb 14, 2024

Upcoming dividend of US$0.39 per share at 8.8% yield

Independent Director recently sold €254k worth of stock

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2023

Third quarter 2023 earnings released: US$0.74 loss per share (vs US$0.51 loss in 3Q 2022)

Nu Skin Enterprises, Inc. Announces Quarterly Dividend, Payable on December 6, 2023

Nu Skin Enterprises, Inc. to Report Q3, 2023 Results on Nov 01, 2023

New minor risk - Insider selling

Upcoming dividend of US$0.39 per share at 6.4% yield

Nu Skin Enterprises, Inc. Provides Earnings Outlook for the Third Quarter and Full-Year 2023

Nu Skin Enterprises, Inc. Announces Quarterly Dividend, Payable on September 6, 2023

Second quarter 2023 earnings released: EPS: US$0.54 (vs US$0.68 in 2Q 2022)

Nu Skin Enterprises, Inc. Appoints James D. Thomas as Chief Financial Officer

Nu Skin Enterprises, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Nu Skin Enterprises, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Nu Skin Enterprises, Inc.(NYSE:NUS) dropped from Russell 2000 Growth Index

Upcoming dividend of US$0.39 per share at 4.2% yield

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Second Quarter and Full Year Ended March 31, 2023

First quarter 2023 earnings released: EPS: US$0.23 (vs US$0.77 in 1Q 2022)

Nu Skin Enterprises Announces Quarterly Dividend, Payable on June 7, 2023

Chief Accounting Officer recently sold €110k worth of stock

Full year 2022 earnings released: EPS: US$2.10 (vs US$2.93 in FY 2021)

Nu Skin Enterprises, Inc. Announces Dividend Increase, Payable on March 8, 2023

Nu Skin Enterprises, Inc. to Report Q4, 2022 Results on Feb 15, 2023

Nu Skin Enterprises, Inc.(NYSE:NUS) dropped from S&P 400 Consumer Staples (Sector)

Nu Skin Enterprises Introduces the Next Generation of Smart Skincare with ageLOC LumiSpa iO

Upcoming dividend of US$0.39 per share

Third quarter 2022 earnings released: US$0.51 loss per share (vs US$0.99 profit in 3Q 2021)

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022

Nu Skin Enterprises, Inc. to Report Q3, 2022 Results on Nov 02, 2022

Chief Accounting Officer recently sold €63k worth of stock

Insider recently sold €254k worth of stock

Upcoming dividend of US$0.39 per share

Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2022

Second quarter 2022 earnings released: EPS: US$0.68 (vs US$1.18 in 2Q 2021)

Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on September 7, 2022

Nu Skin Enterprises, Inc. Provides Revenue Guidance for the Second Quarter of 2022

Executive Chairman of the Board recently sold €955k worth of stock

Upcoming dividend of US$0.39 per share

First quarter 2022 earnings released: EPS: US$0.77 (vs US$0.94 in 1Q 2021)

Nu Skin Enterprises Announces Quarterly Dividend, Payable on June 8, 2022

Nu Skin Enterprises, Inc. to Report Q1, 2022 Results on May 04, 2022